Data / Form D filings / NOMOCAN PHARMACEUTICALS LLC
NOMOCAN PHARMACEUTICALS LLC: Form D filings
NOMOCAN PHARMACEUTICALS LLC, a pharmaceuticals company in Brooklyn, NY, filed 2 Form D notices with the SEC between 2014 and 2015. The latest, on February 10, 2015, reports $740,000 sold of a $2 million offering.
Find out what NOMOCAN PHARMACEUTICALS LLC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 760 PARKSIDE AVENUE, ROOM 205, Brooklyn, NY, 11203
- Phone
- (347) 712-1635
- Industry
- Pharmaceuticals
- Entity type
- Limited Liability Company
- Incorporated in
- New York
- Year incorporated
- 2014
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1620915
The full lists. Form D filings in New York: 4,357 rows, $123.57, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 10, 2015 | Amendment | $2,000,000 | $740,000 | $1,260,000 | 0 | Yet to occur | sec.gov |
| Nov 10, 2014 | New notice | $2,000,000 | $0 | $2,000,000 | 0 | Yet to occur | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Josef Michl | Executive Officer | |
| Ehsan Sarafraz-Yazdi | Executive Officer |
Other pharmaceuticals companies in New York that filed recently
- NBO Pharma Inc. $238,000 · Nov 9, 2026
- Pierrepont Therapeutics, Inc. $2.4 million · Sep 22, 2026
Every Form D from the week of Feb 9, 2015 · All recent filings in New York · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what NOMOCAN PHARMACEUTICALS LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.